Definitive Contract 75N91020C00007
Award Date 9/30/20
Potential Completion Date 9/29/27
Potential Value $7.9M
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Baltimore, MD 21201, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $6,885,849.71 cost-reimbursement contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) to serve as the resource for the collection and evaluation of human tissue, cells, and bio-fluids from donors with an epidemiologic profile. The award supports medical research activities and does not have a set-aside designation. The contract has an ultimate completion date of September...
- This federal contract award was issued by the National Cancer Institute, a civilian agency of the U.S. government, to the University of Maryland, Baltimore (UMB), doing business as the Baltimore Campus. The $13,596 firm fixed-price delivery order was awarded on September 20, 2013 with a completion date of September 16, 2017. No set-aside designation was used. The University of Maryland, Baltimore is a major public research university that frequently receives federal funding through contracts and...
- University of Maryland, Baltimore has been awarded a $10,923 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for tuition assistance with no set aside designation. It will be completed by August 26, 2024 in support of research initiatives at the National Cancer Institute's campus located in Baltimore, Maryland. As an academic institution and medical center, University of Maryland, Baltimore...
- This is a $29,057,109.85 definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) for biomedical research and development. The contract has no set-aside designation. UMB, a major public research university, is the prime contractor and frequently receives federal contracts and grants for its expertise in areas such as medicine, nursing,...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $10,109 purchase order to the University of Maryland, Baltimore for tuition assistance. The firm fixed price contract runs from November 13, 2023 to December 22, 2023 and will provide funding to the prime contractor, a subsidiary of the University System of Maryland, for educational services. No major subcontractors or set aside designations were identified. The National Cancer...
- This is a firm-fixed price purchase order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to the University of Maryland, Baltimore (UMB), a public research university. The contract is valued at $10,151.50 and supports tuition assistance for the State of Maryland. The contract does not have a set-aside designation. UMB has received numerous federal contract awards and grants from various agencies, including the Departments...
- This is a federal contract award to the University of Maryland, Baltimore (UMB), a major public research university, for biomedical research and services. The $510,342.33 definitive contract was awarded on December 13, 1996 by the National Institutes of Health (NIH), a civilian agency, with a period of performance through December 31, 2005. The contract has a "Cost No Fee" pricing type, and was not set aside for any special business category. UMB, the prime contractor, provides a...
- This federal contract award, valued at $11,834,751.80, was issued by the National Institutes of Health (NIH) to the University of Maryland, Baltimore (UMB) to provide support for the Office of AIDS Research Initiative's research grant activities. The contract is a definitive, firm-fixed-price agreement with a period of performance ending on September 27, 2027. UMB, a prominent academic health sciences institution, will deliver a range of sophisticated biomedical research, clinical services,...
- This contract award is for $600,000 to provide support services for the In-Depth Cell Characterization Hub (IDCCH) under the National Institutes of Health (NIH) Regenerative Medicine Innovation Project (RMIP). The prime contractor is the University of Maryland, Baltimore (UMB), which is the founding campus of the University System of Maryland (USM). The contract is a firm fixed price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Maryland, Baltimore (UMB) in the amount of $15,000.00. The contract does not have a set-aside designation. UMB, a major public research university, provides a wide range of goods and services to the federal government, including biomedical and clinical research, healthcare services, and professional education and training. This contract award likely...